How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners.
暂无分享,去创建一个
Pam Sonnenberg | P. Sonnenberg | K. Fielding | J. Murray | J. Glynn | P. Godfrey-Faussett | Jill Murray | Judith R Glynn | Peter Godfrey-Faussett | Katherine Fielding | Stuart Shearer | S. Shearer
[1] P. Sonnenberg,et al. HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV , 2004, AIDS.
[2] P Godfrey-Faussett,et al. Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. , 2000, AIDS.
[3] S. Vermund,et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[4] R. Coutinho,et al. How does tuberculosis relate to HIV positive and HIV negative drug users? , 2000, Journal of epidemiology and community health.
[5] S. Blower,et al. Amplification Dynamics: Predicting the Effect of HIV on Tuberculosis Outbreaks , 2001, Journal of acquired immune deficiency syndromes.
[6] P. Sonnenberg,et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community , 2000, The Lancet.
[7] H. Yanai,et al. The Evolving Epidemiology of HIV Infection and Tuberculosis in Northern Thailand , 2002, Journal of acquired immune deficiency syndromes.
[8] F. Plummer,et al. Recent transmission of tuberculosis in a cohort of HIV‐1‐infected female sex workers in Nairobi, Kenya , 1997, AIDS.
[9] F. Behets,et al. Effect of HIV-1 infection on tuberculosis and fertility in a large workforce in Kinshasa, Democratic Republic of the Congo. , 2000, AIDS Patients Care and STDs.
[10] Hiv Survival,et al. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.
[11] C. Murray,et al. Modeling the impact of global tuberculosis control strategies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Fitzgerald,et al. An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection. , 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] G. Ippolito,et al. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). , 1995, JAMA.
[14] P E Fine,et al. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection , 1997, Epidemiology and Infection.
[15] Jeffrey L. Jones,et al. HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[16] J. Pape,et al. HIV infection in Haiti: natural history and disease progression , 2000, AIDS.
[17] G. Maartens,et al. Risk Factors for Developing Tuberculosis in HIV‐1‐Infected Adults From Communities With a Low or Very High Incidence of Tuberculosis , 2000, Journal of acquired immune deficiency syndromes.
[18] M. M. Braun,et al. A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. , 1991, The American review of respiratory disease.
[19] M. Diomande,et al. The mortality and pathology of HIV infection in a West African city , 1993, AIDS.
[20] R. Cowie,et al. Criteria for the diagnosis of pulmonary tuberculosis. , 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[21] A. Grant,et al. Natural history and spectrum of disease in adults with HIV/AIDS in Africa. , 1997, AIDS.
[22] R. Wood,et al. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study , 2002, The Lancet.
[23] R. Salamon,et al. Clinical and Biological Evolution of HIV‐1 Seroconverters in Abidjan, Côte d’Ivoire, 1997‐2000 , 2002, Journal of acquired immune deficiency syndromes.
[24] K. Jochelson,et al. Human Immunodeficiency Virus and Migrant Labor in South Africa , 1991, International journal of health services : planning, administration, evaluation.
[25] R. Brettle,et al. Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion , 2003, AIDS.
[26] O. Ferreira,et al. Tuberculosis and HIV infection among female inmates in São Paulo, Brazil: a prospective cohort study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[27] P. Sonnenberg,et al. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. , 1999, American journal of respiratory and critical care medicine.
[28] R. Hayes,et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners , 2000, AIDS.
[29] Christopher Dye,et al. Prospects for worldwide tuberculosis control under the WHO DOTS strategy , 1998, The Lancet.
[30] G. Ippolito,et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection , 2000, AIDS.
[31] P. Narciso,et al. Risk Factors for Tuberculosis in HIV-lnfected Persons: A Prospective Cohort Study , 1995 .
[32] G H Guyatt,et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. , 1999, AIDS.
[33] D. Holtzman,et al. Tuberculosis and acquired immunodeficiency syndrome--Florida. , 1989, MMWR. Morbidity and mortality weekly report.
[34] W. Morgan. The relationship between tuberculosis and silicosis. , 2015, The American review of respiratory disease.
[35] G. Ippolito,et al. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. , 2000 .
[36] C. Mahé,et al. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. , 2002, BMJ : British Medical Journal.
[37] C. Power,et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. , 2000 .
[38] J. Caylà,et al. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[39] J. Mellors,et al. Natural history of HIV-1 infection. , 2000, Infectious disease clinics of North America.
[40] R. Salamon,et al. Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988-1993. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[41] K. Kerlikowske,et al. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. , 1992, The American review of respiratory disease.